Breast cancer progression: the devil is in the details

Posted by on April 27, 2016 2:36 pm
Categories: health

Researchers describe how breast cancer cells challenged with a small-molecule inhibitor targeting specific invasive properties switch to an alternative mode-of-action, rendering them even more aggressive. The results may impair future therapeutic approaches in the TGF-beta pathway.

Leave a Reply

Your email address will not be published. Required fields are marked *